AGP Executive Report
Last update: 9 hours agoDrug Safety Tech: Deep Origin’s PREDICTS consortium is rolling out new in silico ADMET models to screen millions of compounds, aiming for faster, safer drug development using human-based virtual organ models. Cardiac Research Access: Bit.bio and Myriamed are expanding access to functional iPSC-derived cardiomyocytes to improve early detection of cardiotoxicity and drug-induced liver injury risks. Postmarket Study Delays: A KFF Health News report highlights how FDA-required follow-up safety studies for approved drugs like Tavneos are often delayed, leaving patients and clinicians in the dark about real-world risks. UN Health & Equity: UN-linked coverage points to microfinance and social business models that expand healthcare access, including telehealth and eye-care, while UN discussions also stress the right to development and tackling inequality. Local Health Watch: In Cebu City, officials were urged to fix a “dirty” sputum collection area—an example of how basic facility hygiene affects disease testing quality. Timor-Leste Link: Timor-Leste President José Ramos-Horta met Vietnam’s top leader in New York, with cooperation plans that could support development priorities including health.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.